The Development of Anti-Retroviral Therapy in Africa (DART) trial. What have we learnt?

From:
Department for International Development
Published
1 January 2009
Country:
Uganda, Zimbabwe
Document Type:
Conference Paper
Theme:
Health
Authors:
Hakim, J.

Abstract

It is concluded that:

  • DART provides clear evidence to help governments and policymakers determine priorities for ART programmes
  • DART adds to the evidence base for ART in Africa in ways beyond those originally anticipated
  • DART created highly skilled teams of ART clinical trialists and centres of ART and research excellence in Uganda and Zimbabwe
  • Partnerships have been developed,additional resources leveraged and a broader scientific agenda realised

Citation

Presented at the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Cape Town, South Africa, 19-22 July 2009, 22 pp.

The Development of Anti-Retroviral Therapy in Africa (DART) trial. What have we learnt?

Updates to this page

Published 1 January 2009
Contents